This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA
Book Now
Menu
Book

Greg Hoffman, PhD
Chief Scientific Officer at Deep Genomics
Speaker

Agenda Sessions

  • Applying Machine Learning to Identify Differentiated Target Mechanisms and Design Next-Generation Oligonucleotide Therapeutics

    , 10:45am
    View Session

At this event

Prev
Next
Marc Abrams, PhD
Chief Technology Officer & Head, US Operations
SanegeneBio

See Greg at TIDES USA: Oligonucleotide & Peptide Therapeutics

Book Now